Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 17 of 17

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract September 2016

Variations in the size of retinal cysts as a tomographic factor predictor for retreatment with Ozurdex in patients with refractory diabetic macular edema

Félix Alexander Manco Lavado; María Rosalba Ramoa Osorio; M Isabel Lopez; Lucía Manzanas Leal; Ignacio Alonso de la Fuente; Mercedes Hernando Verdugo

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3262.

ARVO Annual Meeting Abstract June 2015

Characterization of exosomes liberated from damaged RPE: implication in new blood vessel formation due to overexpression of VEGF receptor 1 and 2

Javier Sancho-Pelluz; Sandra Atienzar-Aroca; Miguel Flores-Bellver; Gemma Serrano-Heras; Natalia Martinez-Gil; Jorge M Barcia; Silvia Aparicio; Daniel Perez-Cremades; Jose Manuel Garcia-Verdugo; Francisco J Romero

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):2390.

ARVO Annual Meeting Abstract April 2010

Automated Processing of HRT Corneal Images to Objectively Assess Changes in Corneal Health

C. W. Sindt; B. Lay; J. R. Kern; M. E. Verdugo

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):5665.

ARVO Annual Meeting Abstract May 2008

A Fast, High Resolution System for Converting 35mm Ophthalmic Slides to Digital Images

M. E. Verdugo; P. Nadolny; J. Buonomo; A. Sasai; B. Lay; G. Dagniaux

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):1841.

ARVO Annual Meeting Abstract May 2005

Autofluorescence Pattern in Fellow Eyes of Patients With Occult Choroidal Neovascularization: Three Year Follow–Up

U.E. K. Schnurrbusch; W. Einbock; M. Verdugo; S. Wolf

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):229.

ARVO Annual Meeting Abstract May 2005

Towards Development of Quantitative Techniques for Analyizing Ophthalmological Images

M.E. Verdugo; P. Soliz; S. Wolf; B. Wyman

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):246.

ARVO Annual Meeting Abstract May 2005

The Effect of Fundus Image Quality on Detecting Clinically Significant Features in Fundus Imaging

B. Raman; S. Russell; M. Verdugo–Gazdik; S. Nemeth; S. Wolf; P. Soliz; E. Butler

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):272.

ARVO Annual Meeting Abstract May 2005

Assessment of Fill–Rate Statistics to Automatically Segment and Classify Choroidal Neovascular Lesions in Age–Related Macular Degeneration

I. Benche; S. Madden; S. Nemeth; S. Russell; M. Verdugo–Gadzik; S. Wolf; P. Soliz

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):1564.

ARVO Annual Meeting Abstract May 2005

Noninvasive Measurement of Mitochondrial Function in Space, Time, and Depth in Retinal Tissue: Metabolic Mapping

R. Zuckerman; J. Myers; M.E. Verdugo–Gazdik; D. Markle; J. Smith; D.S. Lester

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):4759.

ARVO Annual Meeting Abstract May 2004

Early MNU–induced retinal toxicity detected by electroretinography and visual acuity in funduscopically normal rats

C.–N. Liu; D. Simic; D. Baltrukonis; C. Doshna; J. Render; J. Fortner; M. Verdugo; W. Weisenburger; C. Somps

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):804.

ARVO Annual Meeting Abstract May 2004

Three year follow–up of occult choroidal neovascularization in patients with age–related macular degeneration: Changes in visual acuity

S. Wolf; A. Nestler; P. Gaebler; M.B. Reichel; U.E. K. Schnurrbusch; A. Moessner; M. Verdugo

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):2359.

ARVO Annual Meeting Abstract May 2004

Investigating Cytoskeletal Alterations as a Potential Marker of Retinal and Lens Drug Related Toxicity

M.E. Verdugo; D. Simic; A.B. Jakowski; D.J. Baltrukonis; C.J. Somps; M.W. Tengowski

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):3653.

ARVO Annual Meeting Abstract May 2004

Evaluation of Lens Transparency using Scheimpflug Photography and Slit Lamp Biomicroscopy in the CJ–12,918 Cataract Model in the Albino Rat

D.J. Baltrukonis; C.M. Doshna; J.H. Fortner; J.A. Render; M.E. Verdugo; C.J. Somps

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):355.

ARVO Annual Meeting Abstract May 2003

Comparisons between U18666A, Naphthalene, and Galactose on Lens Cholesterol Biosynthesis and Evaluation of Cataract Progression by Scheimpflug and Slit Lamp Exams

D.J. Baltrukonis; J.H. Fortner; C.J. Somps; A.M. Ryan; M.D. Aleo; M.E. Verdugo

Invest. Ophthalmol. Vis. Sci.. 2003; 44(13):3489.

ARVO Annual Meeting Abstract May 2003

Evaluation of a Human Lens Epithelial Cell Line for Electrophysiologic Markers of Cataractogenic Potential

M.E. Verdugo; C. Liu; C.J. Somps

Invest. Ophthalmol. Vis. Sci.. 2003; 44(13):4474.

ARVO Annual Meeting Abstract December 2002

Role of Small GTPases in Lovastatin and CJ-12,918-Induced Cataracts

DJ Baltrukonis; S Kajiji; LF Nelms; MP Lawton; MD Aleo; ME Verdugo

Invest. Ophthalmol. Vis. Sci.. 2002; 43(13):3542.

ARVO Annual Meeting Abstract December 2002

Investigation of the Role of Apoptosis in Drug-induced Cataract Formation

CW Doshna; JH Fortner; JC Pfohl; MD Aleo; MW Tengowski; ME Verdugo

Invest. Ophthalmol. Vis. Sci.. 2002; 43(13):2377.

Advertisement